Association of Mitral Regurgitation with Postoperative Atrial Fibrillation in Critically Ill Noncardiac Surgery

Jin Zhang1, Jingyi Wang1, Yijia Jiang1

  • 1Surgical Intensive Care Unit, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.

Abstract

Insights

Mitral regurgitation (MR) is an independent risk factor for postoperative atrial fibrillation (POAF) in critically ill patients undergoing noncardiac surgery. A new MR-based nomogram demonstrates superior prediction of POAF compared to existing scoring systems.

Area of Science:

  • Critical Care Medicine
  • Cardiology
  • Surgical Outcomes

Background:

  • Postoperative atrial fibrillation (POAF) is a significant complication in critically ill patients after noncardiac surgery, yet remains understudied.
  • Mitral regurgitation (MR) is linked to left ventricular dysfunction and may contribute to AF development in the postoperative period.

Purpose of the Study:

  • To investigate the association between mitral regurgitation (MR) and POAF in critically ill patients following noncardiac surgery.
  • To develop and validate a novel nomogram for predicting POAF in this patient population.

Main Methods:

  • A prospective cohort study included 2474 patients undergoing thoracic and general surgery.
  • Preoperative echocardiography, ECG, clinical data, and established scoring systems were analyzed.
  • A nomogram was constructed and validated using logistic regression, ROC, DCA, NRI, and IDI analyses.

Main Results:

  • 8.6% of patients developed POAF within 7 days of ICU admission.
  • The developed MR-nomogram exhibited superior predictive performance for POAF (AUC = 0.824) compared to CHA2DS2-VASc, HATCH, COM-AF, HART, and C2HEST.
  • The MR-nomogram demonstrated significant improvements in predictive value and net benefit.

Conclusions:

  • Mitral regurgitation (MR) is identified as an independent risk factor for POAF in critically ill noncardiac surgery patients.
  • The novel MR-nomogram offers enhanced predictive accuracy for POAF over existing clinical scoring systems.

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
33
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
58
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
22
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
25
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
23